Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 25,695 |
|
|||||
| News | - | ||||||
| Day High | 1.25 | Low High |
|||||
| Day Low | 1.1006 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Passage Bio Inc | PASG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.08 | 7.02% | 1.22 | 12:20:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.11 | 1.1006 | 1.25 | 1.14 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 114 | 25,695 | $ 1.16 | $ 29,909 | - | 0.5751 - 1.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:20:10 | 200 | $ 1.22 | USD |
Passage Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 68.39M | 55.60M | - | 0 | -102.06M | -1.84 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Passage Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PASG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.24 | 1.30 | 1.1006 | 1.18 | 123,297 | -0.02 | -1.61% |
| 1 Month | 1.33 | 1.45 | 1.1006 | 1.30 | 162,695 | -0.11 | -8.27% |
| 3 Months | 0.90 | 1.79 | 0.90 | 1.38 | 372,020 | 0.32 | 35.56% |
| 6 Months | 0.6735 | 1.79 | 0.5751 | 1.01 | 503,007 | 0.5465 | 81.14% |
| 1 Year | 0.9908 | 1.79 | 0.5751 | 0.9650095 | 353,259 | 0.2292 | 23.13% |
| 3 Years | 17.62 | 19.84 | 0.5751 | 4.05 | 331,961 | -16.40 | -93.08% |
| 5 Years | 22.27 | 38.23 | 0.5751 | 8.09 | 316,966 | -21.05 | -94.52% |
Passage Bio Description
| Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. |
